Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03
September 09, 2019 06:00 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today announced that it has engaged Catalent Pharma Solutions, LLC (“Catalent”) to initiate...
Acura Pharmaceuticals Licenses LIMITx™ LTX-03
July 02, 2019 16:30 ET
|
Acura Pharmaceuticals, Inc.
Agreement Provides For Completion of Development and CommercializationTransaction Valued at up to $21.3 Million, not including Royalties PALATINE, Ill., July 02, 2019 (GLOBE NEWSWIRE) -- Acura...
Acura Pharmaceuticals Announces Third Quarter 2018 Financial Results
November 27, 2018 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals, Inc. Restructures Debt Obligations
October 09, 2018 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company focused on innovating abuse deterrent drugs, today announced that on...
Acura Pharmaceuticals Announces Second Quarter 2018 Financial Results
August 14, 2018 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces First Quarter 2018 Financial Results
June 29, 2018 16:10 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., June 29, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces Fourth Quarter 2017 and Full Year 2017 Financial Results
June 07, 2018 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., June 07, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301
January 08, 2018 06:00 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results...
Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
November 13, 2017 16:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for...
Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology
October 09, 2017 06:15 ET
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results...